Jose Manuel Otero, Ph.D.

Jose Manuel Otero, Ph.D.

Chief Technical OfficeratLexeo Therapeutics· In proxies 2023–2024

Pay in FY2024Lexeo Therapeutics stock -51.0% the same year

Jose Manuel Otero, Ph.D. was paid $3.6M in FY2024 (Dec). Lexeo Therapeutics stock fell 51.0% that year.

Pay$100 in the stock at the end of FY23 → $49
Pay is from the Summary Compensation Table of each Lexeo Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lexeo TherapeuticsPublic company · 3 yr
    • Chief Technical Officer2023 – Present · 3 yrStock in role -69%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?